Medicare Enrolled
Dr. Ronald Anglade, M.D.
Urology Physician · Snellville, GA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Anglade from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Anglade?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Anglade
Dr. Ronald Anglade is an urology physician in Snellville, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Anglade performed 1,384 Medicare services across 1,118 unique beneficiaries.
Between the years covered by Open Payments, Dr. Anglade received a total of $27,235 from 67 pharmaceutical and/or device companies across 857 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Anglade is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ 1,384 Medicare services
$27,235 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,384
Medicare services
Bottom 42% in GA for urology physician
1,118
Unique beneficiaries
$76
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~73 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
450 | $92 | $233 |
| PSA test (prostate cancer screening) | 171 | $18 | $109 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
97 | $214 | $386 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
97 | $2 | $22 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
86 | $59 | $696 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
77 | $14 | $204 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
76 | $4 | $106 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
76 | $88 | $188 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
70 | $118 | $350 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
33 | $25 | $82 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
29 | $25 | $111 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
23 | $8 | $78 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
21 | $65 | $119 |
| Waterjet prostate destruction via urethra A procedure that uses a high-pressure water jet to destroy prostate tissue, accessed through the urethra. |
17 | $593 | $5,000 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
16 | $102 | $1,606 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
16 | $95 | $606 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
15 | $24 | $85 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
14 | $102 | $195 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.2% high complexity
6.3% medium
92.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$27,235
Total received (2018-2024)
Avg $3,891/year across 7 years
Top 8% in GA for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
67
Companies
857
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$26,909 (98.8%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$326 (1.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,973
2023
$4,610
2022
$5,389
2021
$3,795
2020
$2,003
2019
$5,497
2018
$1,968
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$1,172
COLOPLAST CORP
$723
Axonics, Inc.
$204
Merck Sharp & Dohme LLC
$203
Sumitomo Pharma America, Inc.
$158
Valencia Technologies Corporation
$139
Tolmar, Inc.
$130
Endo Pharmaceuticals Inc.
$114
PFIZER INC.
$113
Tempus AI, Inc
$103
Dendreon Pharmaceuticals LLC
$102
AstraZeneca Pharmaceuticals LP
$97
Bayer Healthcare Pharmaceuticals Inc.
$92
Endo USA, Inc.
$90
ABBVIE INC.
$86
Ferring Pharmaceuticals Inc.
$84
Antares Pharma, Inc.
$68
Teleflex LLC
$55
Olympus America Inc.
$51
PROCEPT BioRobotics Corporation
$48
UROGEN PHARMA, INC.
$38
Calyxo, Inc.
$25
Myriad Genetic Laboratories, Inc.
$25
Blue Earth Diagnostics Limited
$24
Verity Pharmaceuticals Inc.
$15
Photocure Inc
$14
Top 3 companies account for 52.8% of 2024 payments
All-time payments by company (2018-2024) ›
Coloplast Corp
$3,300
Boston Scientific Corporation
$3,297
NeoTract Inc.
$3,081
Teleflex LLC
$2,330
Axonics, Inc.
$2,112
Endo Pharmaceuticals Inc.
$1,384
PROCEPT BioRobotics Corporation
$1,351
COLOPLAST CORP
$1,137
Antares Pharma, Inc.
$779
Blue Earth Diagnostics Limited
$771
PFIZER INC.
$609
Astellas Pharma US Inc
$600
Merck Sharp & Dohme LLC
$523
Bayer HealthCare Pharmaceuticals Inc.
$493
Myovant Sciences Inc.
$408
Dendreon Pharmaceuticals LLC
$398
AstraZeneca Pharmaceuticals LP
$363
Sumitomo Pharma America, Inc.
$328
TOLMAR Pharmaceuticals, Inc.
$282
Tolmar, Inc.
$277
Janssen Biotech, Inc.
$222
BOSTON SCIENTIFIC CORPORATION
$201
Amgen Inc.
$179
Merck Sharp & Dohme Corporation
$178
Bayer Healthcare Pharmaceuticals Inc.
$175
Ferring Pharmaceuticals Inc.
$171
Lexington Medical, Inc.
$162
AngioDynamics, Inc.
$148
Valencia Technologies Corporation
$139
Supernus Pharmaceuticals, Inc.
$132
UROVANT SCIENCES INC
$124
Foundation Medicine, Inc.
$122
Acerus Pharmaceuticals Corporation
$107
Tempus AI, Inc
$103
Olympus America Inc.
$99
Axonics Modulation Technologies, Inc.
$94
Allergan, Inc.
$90
Endo USA, Inc.
$90
ABBVIE INC.
$86
Rochester Medical Corporation
$85
Alnylam Pharmaceuticals Inc.
$81
MEDIVATION FIELD SOLUTIONS LLC
$69
AbbVie Inc.
$55
UROGEN PHARMA, INC.
$53
Myriad Genetic Laboratories, Inc.
$41
ABC Home Medical Supply, Inc.
$38
Allergan Inc.
$37
Avadel Specialty Pharmaceuticals, LLC
$32
Calyxo, Inc.
$25
Photocure Inc
$25
AbbVie, Inc.
$22
RGH Enterprises, Inc.
$19
UroGen Pharma, Inc.
$19
Metuchen Pharmaceuticals
$18
Progenics Pharmaceuticals, Inc.
$18
Kowa Pharmaceuticals America, Inc.
$18
180 Medical, Inc.
$18
Janssen Pharmaceuticals, Inc
$17
Verity Pharmaceuticals Inc.
$15
Zyla Life Sciences
$14
Laborie Medical Technologies Corp.
$13
Mission Pharmacal Company
$13
NxThera, Inc.
$13
Ambu Inc.
$12
Baxter Healthcare
$11
Travere Therapeutics, Inc.
$8
Retrophin, Inc.
$4
Top 3 companies account for 35.5% of all-time payments
Associated products mentioned in payments ›
(815) Thiola · ADSTILADRIN · ALTIS · AMS · AMS 700 · AMS 700 CXR RTE KIT · AMS 700 CXR RTE Kit · AMS 800 Artificial Urinary Sphincter · AQUABEAM ROBOTIC SYSTEM · AQUABEAM SYSTEM · AVEED · Aeon Endostapler & Echelon Flex Powered Stapler · Androgel · AquaBeam Robotic System · Axonics · Axonics r-SNM System · Axumin · BOTOX · BOTOX THERAPEUTIC · Bulkamid · CLENPIQ · CONTINENCE CARE · CVAC ASPIRATION SYSTEM · CYSVIEW · Coloplast TFL Drive · Cysview · EDEX · ELIGARD · ERLEADA · Erleada · FIRMAGON · FOUNDATIONONE · FOUNDATIONONE CDX · FOUNDATIONONE LIQUID CDX · GEMTESA · GENERAL - BPH · GENERAL - ERECTILE DYSFUNCTION · GENERAL BPH · General - Kidney Stone Disease · General - Male SUI · General - Therapies · JATENZO · JELMYTO · KEYTRUDA · LYNPARZA · LithoVue · Luja Coude · MYRBETRIQ · Myrbetriq · NANOKNIFE · NOCDURNA · Natesto · Noctiva · Non-Covered · Nubeqa · ORGOVYX · OTREXUP · OXLUMO · Olympus · Otrexup · POSLUMA · PROLARIS · PROVENGE · PYLARIFY · Porges Coloplast · Prolaris · REZUM · Rezum · SPACEOAR · SPACEOAR VUE · SPEEDICATH · SPRIX · Seglentis · SpeediCath · Stendra · TISSEEL · TITAN · TLANDO · TOVIAZ · TRIA · Titan · Trelstar · UROLIFT · Uribel · UroLift · UroLift System · VESICARE · XGEVA · XIAFLEX · XTANDI · XYOSTED · Xofigo · Xtandi · ZYTIGA · eCoin Device Kit · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for urology physician in GA.
Geographic Context
Urology physicians within 10 mi
144
Per 100K population
14.9
County median income
$84,823
Nearest hospital
PIEDMONT EASTSIDE MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Anglade is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 8% of GA peers, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Anglade experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Anglade performed 450 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Anglade receive payments from pharmaceutical companies?
Yes. Dr. Anglade received a total of $27,235 from 67 companies across 857 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Anglade's costs compare to other urology physicians in Snellville?
Dr. Anglade's average Medicare payment per service is $76. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Anglade) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Snellville
Browse urology physicians in Snellville ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in GA
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in GA
Which GA urology physicians receive the most from drug and device companies.
By company
Coloplast Corp Payments to Doctors
See all physicians who received payments from Coloplast Corp.
By company
Boston Scientific Corporation Payments to Doctors
See all physicians who received payments from Boston Scientific Corporation.
By company
NeoTract Inc. Payments to Doctors
See all physicians who received payments from NeoTract Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology